{"text": ["The", "biggest", "challenges", "facing", "vaccine", "distribution"], "created_at": "2020-12-04 21:53:21"}
{"text": ["Why", "BioCryst,", "Moderna", "And", "More", "Are", "Moving", "Today"], "created_at": "2020-12-04 17:59:01"}
{"text": ["Coronavirus", "update:", "Fauci", "to", "become", "Biden's", "chief", "medical", "adviser;", "United", "Health", "Group", "to", "study", "Eli", "Lilly", "antibody"], "created_at": "2020-12-04 17:14:42"}
{"text": ["Eli", "Lilly", "Rises", "on", "New", "Trial", "to", "Treat", "Covid", "in", "High-Risk", "Patients"], "created_at": "2020-12-04 16:31:00"}
{"text": ["Vaccines", "and", "Approved", "Antibodies", "Dim", "Vir", "Biotechnology\u2019s", "Covid", "Opportunity,", "Analyst", "Says"], "created_at": "2020-12-04 15:11:00"}
{"text": ["Pharma", "Stock", "Roundup:", "Approval", "of", "PFE/BNTX", "Coronavirus", "Vaccine", "in", "UK,", "Other", "Updates"], "created_at": "2020-12-04 13:37:01"}
{"text": ["Lilly", "and", "UnitedHealth", "Group", "partner", "on", "pragmatic", "study", "of", "neutralizing", "antibody", "bamlanivimab", "(LY-CoV555)", "for", "COVID-19"], "created_at": "2020-12-04 13:00:00"}
{"text": ["Lilly", "and", "UnitedHealth", "launch", "trial", "of", "COVID-19", "antibody"], "created_at": "2020-12-04 13:00:00"}
